Pain relief with transdermal buprenorphine and diclofenac patch

COMPARISON OF DICLOFENAC AND BUPRENORPHINE PATCH APPLICATION AND ITS EFFECT ON DISCHARGE CRITERIA IN PATIENTS UNDERGOING MINIMALLY INVASIVE SPINE SURGERIES

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/12/038451

Enrollment

Registered

2021-12-06

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Buprenorphine: 10mg transdermal patch,12hrs before surgery Control Intervention1: Transdermal patch application: Transdermal patch application preoperatively 12hrs before surgery during

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade I â?? III patients Aged 18 â?? 65 yrs Patients willing to participate Patients undergoing lumbar spine fixation Any sex.

Exclusion criteria

Exclusion criteria: 1) Opioid dependant and sensitive patients 2) patients in spinal shock 3) Morbidly obese patients 4) Hypersensitivity to drug 5) Hepatic failure 6) Renal failure 7) Cardiac or respiratory compromise

Design outcomes

Primary

Measure	Time frame
Effect on discharge criteriaTimepoint: After 12hours of surgery	—

Secondary

Measure	Time frame
Analgesic requirementTimepoint: 12hours	—

Countries

India

Contacts

Public ContactLSNAGASWETHA

NIZAMS INSTITUTE OF MEDICAL SCIENCES

srilatanims@gmail.com9848352882

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026